In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spinal Concepts gets FDA warning on BacFix problem

This article was originally published in Clinica

Failure to keep records about an instrument failure and document how it was fixed has earned Spinal Concepts (Austin, Texas), an FDA warning letter. The company makes the BacFix Thoracolumbar System, the Harmonym PLIF Instrument Set and the Cadence Vue vertebral body replacement device.

During a series of inspections in February, investigators uncovered numerous complaints about a breakage problem involving an instrument used to implant the BacFix. It turned out that the tip on the coldwelder instrument tended to break, the agency said, but there was incomplete information about the problem in the complaint files. Moreover, the firm did not document its many attempts to remedy the apparent design flaw, the FDA said.

The company also failed to establish and maintain procedures for rework and to document rework and re-evaluation activities, failed to document that it investigated whether coldwelder parts were being incorrectly heat treated, and how it dealt with the contract manufacturer who did it, the FDA said. The warning letter also cites the company for failing to follow design controls for Cadence Vue.

The company responded to the agency's letters in February and early June, and continues to review them.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel